|
Cannabis Campaigners' Guide News Database result:
|
|
UK: GW Pharma defends cannabis territory
Richard Wray and Simon Bowers The Guardian
Wednesday 24 Oct 2001 GW Pharmaceuticals, which has spent four years developing medicines based on cannabis, yesterday moved to dispel investors' fears that the government's more relaxed approach to the drug would remove the need for its products. GW believes the more liberal approach to cannabis signalled by the Home Office this week may allow it to widen the number of illnesses it can treat using cannabis-based medicines. GW is developing pain-relief products for patients suffering from severe conditions such as multiple sclerosis and certain types of cancer. Executive chairman Geoffrey Guy said yesterday he welcomed the government's decision. "The more liberal each country's approach is to cannabis - and we are dealing with a number of countries around the world - the easier it is for us to address some of the larger but less severe conditions." On Tuesday home secretary David Blunkett told a Commons select committee that cannabis is to be downgraded from a class B to a class C drug. Mr Blunkett also made it plain that if trials of cannabis-based medicines proved a success the government would change the law to allow doctors to prescribe medicines based on the drug. In a separate development, an ex-employee of a former GW joint enterprise partner is considering legal action over a patent technology used in GW's under-tongue cannabis spray device. The patent was sold to GW by Bioglan following joint research carried out three years ago. But Calvin Ross, who no longer works for Bioglan, is thought to believe the rights to the technology were not assigned to Bioglan. Mr Guy said: "It has been published in our name. End of story for us." A Bioglan spokesman said the firm had never been sued over a patent and had received no notice of intended legal action.
After you have finished reading this article you can click here to go back.
|
This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!